TARDBP and amyotrophic lateral sclerosis: The discrimination ability between ALS and controls was improved by the combined use of CSF TDP‐43 and CSF NfL, therefore CSF TDP‐43 could serve as a biomarker complementary to NfL in the diagnosis of ALS.